News & Updates
Filter by Specialty:
Tirzepatide regulates metabolites, lipids in T2D
Treatment with tirzepatide leads to a reduction in body weight and improvement in glycaemic control in individuals with type 2 diabetes (T2D), reports a study. In addition, it modulates metabolites associated with T2D risk and metabolic dysregulation that is consistent with improved metabolic health.
Tirzepatide regulates metabolites, lipids in T2D
02 Feb 2022
Risk of colorectal cancer mortality after adenoma removal differs by sex
Women appear to be at higher risk of colorectal cancer death following adenoma removal, whereas men are at lower risk, as reported in a recent study.
Risk of colorectal cancer mortality after adenoma removal differs by sex
02 Feb 2022
Waist circumference, not BMI, a good indicator of outcomes in older diabetics
In older patients with type 2 diabetes (T2D), use of body mass index (BMI) does not adequately predict clinical outcomes associated with obesity, but waist circumference (WC) appears to be up to the task.
Waist circumference, not BMI, a good indicator of outcomes in older diabetics
02 Feb 2022
Lifestyle interventions ward off mobility disability in prostate cancer patients on ADT
An exercise and dietary lifestyle intervention regimen leads to better mobility outcomes among prostate cancer patients undergoing androgen deprivation therapy (ADT) as compared with standard-of-care management, a recent study has found. Moreover, social cognitive outcome measures seem to be predictive of such mobility outcomes.
